Appeal No. 2003-0890 Page 6 Application No. 09/706,683 skilled in the art would use in order to determine the activity profile of a given compound. Id., pages 18-19. Under these circumstances, it was the examiner's responsibility to set forth a fact-based explanation as to why use of such an assay to determine the activity profile of a given compound would require undue experimentation. We do not have such an analysis. The enablement rejection is reversed. 2. Obviousness. The examiner relies upon Abou-Gharbia as describing compounds which bind the 5-HT1A receptor. Abou-Gharbia, column 3, lines 5-8. The examiner states that Abou-Gharbia describes at least two compounds which differ from those required by claims 1-3 on appeal in the closest approximation by "lacking instant Y-R1 group." Examiner's Answer, page 7. The examiner specifically points to two compounds described at column 2, lines 22-26 of Abou-Gharbia, i.e., Id. In other words, in the closest approximation the two Abou-Gharbia compounds identified by the examiner contain an ethyl bridging moiety while the compounds required by claims 1-3 can have an ethyl bridging moiety substituted by aryl, e.g., phenyl (Y = -(CH2)m- with m = 0 and R1 = aryl).Page: Previous 1 2 3 4 5 6 7 8 9 10 NextLast modified: November 3, 2007